Joshua Hill, MD
@JoshuaHillMD
Infectious Diseases physician and researcher with a focus on infections in immunocompromised hosts, work at @FredHutch, @UW. Opinions are my own.
ID:1965500118
https://www.fredhutch.org/en/labs/vaccine-and-infectious-disease/about-the-division/research-program 16-10-2013 21:14:48
596 Tweets
1,1K Followers
330 Following
Why do patients on Bruton's tyrosine kinase inhibitors develop aspergillosis?
BTK controls neutrophil p40-phox activation and Rac2-dependent 1 granule release in 🐭 & 👩👨. Collaboration with Mihalis Lionakis CramerLab + many others - Memorial Sloan Kettering Cancer Center
jci.org/articles/view/…
Thank you to the editors of Open Forum Infectious Diseases for publishing my editorial on the ID medical team and opportunities for APP education development. Alison Beieler Fred Hutchinson Cancer Center UW Department of Medicine IDSA
academic.oup.com/ofid/advance-a…
Human Herpes Virus-6 (HHV-6) Reactivation after Hematopoietic Cell Transplant and Chimeric Antigen Receptor (CAR)- T Cell Therapy: A Shifting Landscape mdpi.com/2725978 #mdpiviruses via Viruses MDPI
In Clinical Infectious Diseases, Sara Ruth Kim, MD, and colleagues examine the impact of pre-transplant respiratory virus detection on post-transplant outcomes in pediatric hematopoietic cell transplantation recipients.
Read: bit.ly/3QoTAdE
🔥BREAKING NEWS: Michelle Yong presented the late breaker abstract of the NCIC MRFF investigator initiated #CSMART Trial at #ESCMIDGlobal2024 in Barcelona today. This DB RCT showed that intranasal interferon is safe and effective in reducing the acquisition of COVID infection…
Evidence for human herpesvirus 6B (HHV-6B) as a pulmonary pathogen after hematopoietic cell transplant
Joshua Hill, MD Fred Hutchinson Cancer Center ASTCT
nature.com/articles/s4146…
Next stellar paper by Erika Kampouri and Joshua Hill, MD from Fred Hutchinson Cancer Center out in Blood Journal ⤵️
In a nutshell:
“Our data demonstrate that HHV-6B reactivation and disease are infrequent after CARTx. Routine HHV-6 monitoring is not warranted.”
ashpublications.org/blood/article/…
Well deserved is an understatement-congratulations to Ajit Limaye on winning the ICHS-Global virology award UW Virology UW Infectious Disease Fellowship Program @UW Fred Hutchinson Cancer Center
Happy to have contributed to this informative study on late CMV disease after HCT alongside the amazing and rising international hematologist Dr. Alicja Sadowska-Klasa! Includes insight on late CMV after letermovir prophylaxis. Fred Hutchinson Cancer Center HutchIDSciences
ashpublications.org/bloodadvances/…
Infections are the 2nd most common cause of non-cancer mortailty during cancer treatment. Vaccine preventable illnesses like flu and pneumonias pose the greatest risk. Shingles is debilitating ASCO vaccine guidelines summary 👇Amar Kelkar, MD, MPH, FACP. Key point #vaccinate always and early
Editorial CAR-T cell therapy pts & COVID-19 vax sciencedirect.com/science/articl…
Improved COVID-19 Ab response w/ 4 vaccines post cellular therapy, BCMA RRMM pts superior responses. Qu remain re: hybrid immunity, scheduling, optimal dosing, type post procedure NCIC Transplantation and Cellular Therapy Journal
The Burden of Invasive Fungal Disease Following CAR T-cell Therapy and Strategies for Prevention
Jessica Little, MD Erika Kampouri Daniel Friedman🏳️🌈 Todd McCarty 💊🐉👨⚕️ George Thompson Kontoyiannis John Baddley Joe Vazquez & Sarah Hammond
academic.oup.com/ofid/advance-a…
